Complete Filing Data
BICYCLE THERAPEUTICS PLC reported Stockholders Equity of $609.98 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BICYCLE THERAPEUTICS PLC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$219.0M | -$169.0M | -$180.7M | -$112.7M | -$66.8M | -$51.0M | -$30.6M | -$21.8M | -$16.3M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$3.6M | $1.4M | -$1.7M | $3.8M | -$195.0K | -$1.7M | $216.0K | -$1.8M | $2.4M |
| Revenue From Contract With Customer Excluding Assessed Tax | $72.6M | $35.3M | $27.0M | $14.5M | $11.7M | $10.4M | $13.8M | $7.1M | $2.1M |
| Operating Expenses | $319.7M | $245.1M | $216.9M | $131.1M | $77.3M | $62.4M | $40.1M | $28.9M | $18.3M |
| Nonoperating Income Expense | $28.3M | $36.1M | $10.7M | $2.4M | -$2.9M | $226.0K | -$4.6M | -$496.0K | -$69.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$218.8M | -$173.8M | -$179.2M | -$114.2M | -$68.5M | -$51.7M | -$30.9M | -$22.2M | -$16.3M |
| Income Tax Expense Benefit | $152.0K | -$4.8M | $1.5M | -$1.5M | -$1.7M | -$724.0K | -$254.0K | -$396.0K | -$23.0K |
| Research And Development Expense | $240.3M | $173.0M | $156.5M | $81.6M | $44.9M | $33.1M | $25.5M | $20.8M | $11.9M |
| Operating Income Loss | -$247.1M | -$209.9M | -$189.9M | -$116.7M | -$65.6M | -$52.0M | -$26.3M | -$21.7M | -$16.2M |
| General And Administrative Expense | $79.4M | $72.2M | $60.4M | $49.5M | $32.4M | $29.2M | $14.6M | $8.1M | $6.4M |
| Comprehensive Income Net Of Tax | -$222.6M | -$167.6M | -$182.4M | -$108.9M | -$67.0M | -$52.7M | -$30.4M | -$23.7M | -$13.9M |
| Research And Development Incentives Receivable Current | $35.6M | $35.7M | $24.0M | $19.2M | $10.9M | $9.2M | $6.9M | $6.3M | |
| Deferred Revenue Noncurrent | $35.5M | $91.5M | $110.2M | $41.5M | $52.1M | $25.0M | $4.9M | $14.6M | |
| Deferred Revenue Current | $3.0M | $10.2M | $25.0M | $20.4M | $19.3M | $10.1M | $728.0K | $10.0K | |
| Income Taxes Paid Net | -$717.0K | $792.0K | $562.0K | $2.2M | $73.0K | $124.0K | $117.0K | $73.0K | |
| Non Cash Interest Expense | $211.0K | $383.0K | $442.0K | $468.0K | $78.0K | ||||
| Interest Expense | $3.3M | $3.3M | $3.0M | $457.0K | |||||
| Deferred Income Tax Expense Benefit | -$850.0K | -$5.2M | $3.3M | -$5.0M | -$1.7M | -$673.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$59.1M | -$79.0M | -$60.8M | -$50.8M | -$39.8M | -$26.6M | -$49.9M | -$42.6M | -$39.1M | -$28.3M | -$26.8M | -$27.6M | -$14.7M | -$17.9M | -$16.2M | -$17.4M | -$10.1M | -$12.1M | -$11.3M | -$4.4M | -$9.5M | -$10.2M | -$6.5M | -$6.6M | -$7.7M | -$5.0M | -$2.5M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$108.0K | -$1.9M | -$1.6M | -$2.1M | -$314.0K | $526.0K | $3.8M | -$948.0K | -$316.0K | $902.0K | $2.1M | $920.0K | $313.0K | -$255.0K | -$58.0K | $743.0K | -$1.0K | -$2.2M | -$424.0K | -$1.5M | $1.1M | -$537.0K | -$2.7M | $1.8M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $11.7M | $2.9M | $10.0M | $2.7M | $9.4M | $19.5M | $5.4M | $11.4M | $4.9M | $3.0M | $4.4M | $3.9M | $4.3M | $1.8M | $1.8M | $3.8M | $3.8M | $1.6M | $1.1M | $5.3M | $614.0K | $1.5M | $6.4M | $1.1M | $1.6M | $1.7M | $2.8M |
| Operating Expenses | $77.3M | $89.5M | $80.2M | $66.5M | $56.0M | $51.2M | $56.1M | $54.5M | $46.7M | $32.8M | $31.7M | $31.2M | $18.6M | $19.1M | $17.8M | $20.9M | $14.5M | $14.2M | $12.8M | $10.0M | $10.9M | $9.5M | $9.7M | $8.6M | $8.0M | $6.6M | $5.7M |
| Nonoperating Income Expense | $6.7M | $7.4M | $8.4M | $9.6M | $7.0M | $4.8M | $3.2M | -$9.0K | $2.1M | $1.2M | $25.0K | -$600.0K | -$799.0K | -$796.0K | -$507.0K | -$429.0K | $72.0K | $371.0K | $212.0K | $220.0K | $440.0K | -$2.1M | -$3.1M | $901.0K | -$1.3M | -$21.0K | -$41.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$58.9M | -$79.2M | -$61.8M | -$54.3M | -$39.7M | -$26.9M | -$47.6M | -$43.1M | -$39.7M | -$28.6M | -$27.3M | -$28.0M | -$15.1M | -$18.1M | -$16.5M | -$17.5M | -$10.6M | -$12.2M | -$11.4M | -$4.5M | -$9.8M | -$10.1M | -$6.4M | -$6.6M | -$7.7M | -$5.0M | -$2.9M |
| Income Tax Expense Benefit | $205.0K | -$231.0K | -$1.1M | -$3.4M | $115.0K | -$350.0K | $2.3M | -$517.0K | -$618.0K | -$238.0K | -$447.0K | -$419.0K | -$415.0K | -$160.0K | -$340.0K | -$55.0K | -$465.0K | -$97.0K | -$107.0K | -$138.0K | -$331.0K | $135.0K | $80.0K | $0.00 | -$396.0K | ||
| Research And Development Expense | $58.4M | $71.0M | $59.1M | $48.3M | $40.1M | $34.9M | $39.9M | $39.7M | $32.2M | $22.8M | $19.9M | $14.3M | $10.5M | $11.7M | $9.7M | $7.4M | $8.0M | $7.8M | $6.1M | $6.5M | $6.3M | $5.6M | $4.9M | ||||
| Operating Income Loss | -$65.6M | -$86.6M | -$70.2M | -$63.8M | -$46.6M | -$31.7M | -$50.8M | -$43.1M | -$41.8M | -$29.8M | -$27.3M | -$27.4M | -$14.3M | -$17.3M | -$16.0M | -$10.7M | -$12.6M | -$11.6M | -$10.3M | -$8.0M | -$3.3M | -$6.4M | -$5.0M | ||||
| General And Administrative Expense | $18.9M | $18.5M | $21.1M | $18.3M | $15.9M | $16.4M | $16.3M | $14.8M | $14.5M | $10.0M | $11.8M | $17.0M | $8.1M | $7.3M | $8.1M | $7.2M | $6.2M | $5.0M | $4.8M | $3.0M | $3.4M | $2.3M | $1.7M | ||||
| Comprehensive Income Net Of Tax | -$59.2M | -$80.9M | -$62.3M | -$52.9M | -$40.1M | -$26.0M | -$46.1M | -$43.6M | -$39.4M | -$27.4M | -$24.7M | -$26.6M | -$14.4M | -$18.2M | -$16.2M | -$9.4M | -$12.1M | -$13.5M | -$9.9M | -$11.7M | -$5.4M | -$8.2M | -$7.6M | ||||
| Research And Development Incentives Receivable Current | $67.3M | $60.8M | $46.2M | $58.0M | $46.4M | $39.1M | $17.3M | $12.9M | $26.5M | $11.4M | $16.3M | $13.3M | $7.7M | $14.3M | $11.5M | $6.0M | $10.8M | $8.5M | $10.7M | $9.7M | |||||||
| Deferred Revenue Noncurrent | $74.1M | $82.9M | $82.2M | $97.8M | $94.0M | $98.1M | $107.6M | $115.1M | $83.8M | $41.7M | $46.8M | $46.4M | $45.0M | $25.3M | $25.6M | $26.1M | $27.7M | $28.2M | $9.1M | $9.4M | |||||||
| Deferred Revenue Current | $12.3M | $14.6M | $12.5M | $11.4M | $11.6M | $16.4M | $27.2M | $29.8M | $25.0M | $16.4M | $19.5M | $19.2M | $17.5M | $8.7M | $10.1M | $7.2M | $5.4M | $6.0M | $808.0K | $1.0M | |||||||
| Income Taxes Paid Net | -$35.0K | $11.0K | |||||||||||||||||||||||||
| Non Cash Interest Expense | $104.0K | $102.0K | $135.0K | $93.0K | |||||||||||||||||||||||
| Interest Expense | $821.0K | $814.0K | $821.0K | $808.0K | $817.0K | $883.0K | $818.0K | $823.0K | $819.0K | $522.0K | |||||||||||||||||
| Deferred Income Tax Expense Benefit | -$1.3M | -$767.0K | -$2.1M | -$748.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $610.0M | $793.1M | $370.9M | $270.8M | $346.3M | $95.5M | $93.2M | -$69.8M | -$47.2M | -$33.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $628.7M | $880.1M | $527.0M | $339.2M | $438.7M | $136.0M | $92.1M | $63.4M | $67.7M | $9.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$251.4M | $353.1M | $187.8M | -$99.5M | $302.7M | $43.9M | $28.7M | -$4.3M | $58.3M | |
| Retained Earnings Accumulated Deficit | -$899.8M | -$680.8M | -$511.8M | -$331.1M | -$218.4M | -$151.6M | -$100.6M | -$69.9M | ||
| Property Plant And Equipment Net | $6.0M | $9.5M | $14.5M | $19.1M | $3.1M | $2.3M | $2.3M | $1.8M | ||
| Prepaid Expense And Other Assets Current | $19.2M | $13.4M | $11.4M | $9.0M | $8.0M | $5.1M | $4.9M | $2.1M | ||
| Other Liabilities Noncurrent | $1.0M | $1.1M | $4.6M | $3.8M | $3.3M | $2.6M | $2.0M | $897.0K | ||
| Other Assets Noncurrent | $12.8M | $11.1M | $5.8M | $8.5M | $3.4M | $1.8M | $1.7M | $3.0M | ||
| Liabilities Current | $57.0M | $67.2M | $69.5M | $53.3M | $36.2M | $23.1M | $8.8M | $8.9M | ||
| Liabilities And Stockholders Equity | $717.6M | $956.9M | $595.3M | $410.6M | $479.8M | $161.2M | $110.2M | $81.6M | ||
| Liabilities | $107.6M | $163.8M | $224.4M | $139.8M | $133.5M | $65.7M | $17.0M | $29.3M | ||
| Common Stock Value | $894.0K | $890.0K | $550.0K | $387.0K | $384.0K | $266.0K | $227.0K | $10.0K | ||
| Assets Current | $682.9M | $928.6M | $561.9M | $369.4M | $458.6M | $155.7M | $104.1M | $76.8M | ||
| Assets | $717.6M | $956.9M | $595.3M | $410.6M | $479.8M | $161.2M | $110.2M | $81.6M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$3.5M | $119.0K | -$1.3M | $387.0K | -$3.4M | -$3.2M | -$1.5M | -$1.8M | ||
| Accrued Liabilities Current | $44.4M | $41.2M | $31.5M | $26.5M | $14.2M | $11.6M | $6.1M | $7.0M | ||
| Accounts Payable Current | $9.7M | $15.8M | $13.1M | $6.5M | $2.7M | $1.4M | $1.9M | $1.9M | ||
| Operating Lease Right Of Use Asset | $15.9M | $7.7M | $13.2M | $13.7M | $14.7M | $1.3M | $2.1M | |||
| Operating Lease Liability Noncurrent | $14.1M | $4.0M | $9.4M | $10.9M | $12.1M | $426.0K | $1.3M | |||
| Cash And Cash Equivalents At Carrying Value | $628.1M | $879.5M | $526.4M | $339.2M | $438.7M | |||||
| Accounts Receivable Net Current | $0.00 | $2.0M | $1.0M | $5.5M | $201.0K | $5.0M | ||||
| Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities | $3.2M | $911.0K | $961.0K | $891.0K | ||||||
| Long Term Debt Noncurrent | $30.7M | $30.3M | $29.9M | $14.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $618.5M | $668.9M | $740.3M | $831.0M | $873.8M | $356.0M | $416.0M | $220.1M | $243.2M | $289.5M | $311.4M | $330.3M | $170.8M | $142.1M | $142.1M | $109.6M | $71.0M | $81.8M | $95.3M | $104.6M | -$75.0M | -$63.0M | -$55.0M | -$47.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $648.9M | $722.0M | $793.5M | $891.4M | $961.9M | $457.5M | $572.6M | $340.4M | $293.8M | $361.5M | $372.8M | $407.4M | $259.5M | $198.7M | $195.9M | $149.8M | $96.9M | $109.6M | $96.0M | $108.5M | $59.4M | $47.9M | $53.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$86.5M | -$69.4M | -$45.3M | -$31.3M | $59.9M | $17.5M | -$4.0M | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$879.6M | -$820.5M | -$741.5M | -$628.9M | -$578.1M | -$538.3M | -$462.7M | -$412.8M | -$370.2M | -$301.1M | -$272.8M | -$245.9M | -$200.3M | -$185.7M | -$167.8M | -$134.1M | -$124.0M | -$111.9M | -$96.1M | -$86.7M | ||||
| Property Plant And Equipment Net | $6.9M | $8.3M | $8.7M | $11.5M | $11.6M | $12.8M | $15.6M | $17.6M | $18.3M | $16.2M | $16.8M | $8.8M | $2.4M | $2.4M | $2.6M | $2.0M | $2.2M | $2.2M | $2.2M | $2.0M | ||||
| Prepaid Expense And Other Assets Current | $23.2M | $22.1M | $16.7M | $17.4M | $20.2M | $19.9M | $13.7M | $10.0M | $10.9M | $8.4M | $9.5M | $9.1M | $5.6M | $4.8M | $6.0M | $5.5M | $4.3M | $4.2M | $3.5M | $2.0M | ||||
| Other Liabilities Noncurrent | $1.1M | $1.1M | $1.1M | $6.0M | $4.7M | $4.6M | $4.3M | $4.3M | $4.1M | $3.2M | $3.3M | $3.4M | $3.0M | $3.0M | $2.8M | $2.3M | $2.1M | $2.0M | $1.4M | $1.3M | ||||
| Other Assets Noncurrent | $13.7M | $13.8M | $12.4M | $9.9M | $6.6M | $6.4M | $5.5M | $12.1M | $10.6M | $6.2M | $5.1M | $4.2M | $2.8M | $2.4M | $2.2M | $2.4M | $2.3M | $1.9M | $1.5M | $1.4M | ||||
| Liabilities Current | $69.3M | $77.4M | $57.6M | $56.4M | $69.6M | $49.5M | $69.7M | $72.3M | $53.0M | $41.6M | $41.3M | $35.4M | $30.2M | $23.3M | $20.8M | $17.0M | $17.0M | $16.2M | $8.8M | $9.4M | ||||
| Liabilities And Stockholders Equity | $764.0M | $832.2M | $883.9M | $996.7M | $1.06B | $547.1M | $638.7M | $454.2M | $428.8M | $417.1M | $445.5M | $459.6M | $281.3M | $226.0M | $223.8M | $170.1M | $118.6M | $129.3M | $116.1M | $126.2M | ||||
| Liabilities | $145.5M | $163.3M | $143.6M | $165.7M | $183.5M | $191.1M | $222.7M | $234.1M | $185.6M | $127.7M | $134.1M | $129.3M | $110.5M | $84.0M | $81.8M | $60.5M | $47.6M | $47.5M | $20.7M | $21.7M | ||||
| Common Stock Value | $894.0K | $893.0K | $892.0K | $890.0K | $889.0K | $553.0K | $550.0K | $396.0K | $389.0K | $385.0K | $385.0K | $385.0K | $329.0K | $309.0K | $300.0K | $264.0K | $228.0K | $227.0K | $226.0K | $226.0K | ||||
| Assets Current | $738.8M | $804.3M | $856.1M | $966.2M | $1.03B | $516.0M | $603.0M | $408.4M | $381.3M | $381.3M | $408.5M | $429.8M | $272.9M | $217.8M | $215.4M | $164.2M | $112.5M | $123.4M | $110.3M | $120.5M | ||||
| Assets | $764.0M | $832.2M | $883.9M | $996.7M | $1.06B | $547.1M | $638.7M | $454.2M | $428.8M | $417.1M | $445.5M | $459.6M | $281.3M | $226.0M | $223.8M | $170.1M | $118.6M | $129.3M | $116.1M | $126.2M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$3.5M | -$3.4M | -$1.5M | -$3.2M | -$1.1M | -$778.0K | $2.9M | -$877.0K | $71.0K | $528.0K | -$374.0K | -$2.5M | -$3.2M | -$3.5M | -$3.3M | -$3.0M | -$3.7M | -$3.7M | -$2.6M | -$2.2M | ||||
| Accrued Liabilities Current | $44.4M | $44.5M | $34.0M | $39.3M | $28.1M | $26.0M | $34.1M | $37.3M | $25.2M | $18.1M | $17.0M | $12.3M | $11.0M | $11.1M | $9.7M | $7.8M | $8.2M | $5.7M | $6.0M | $5.9M | ||||
| Accounts Payable Current | $12.7M | $18.3M | $11.1M | $5.7M | $7.5M | $7.1M | $8.5M | $5.3M | $2.8M | $7.1M | $4.9M | $4.0M | $1.8M | $3.5M | $996.0K | $2.1M | $3.3M | $4.4M | $2.0M | $2.6M | ||||
| Operating Lease Right Of Use Asset | $4.6M | $5.8M | $6.7M | $9.1M | $10.9M | $12.0M | $14.6M | $16.0M | $18.7M | $13.5M | $15.1M | $16.8M | $3.2M | $3.5M | $3.7M | $1.5M | $1.6M | $1.8M | $2.2M | $2.4M | ||||
| Operating Lease Liability Noncurrent | $981.0K | $1.8M | $2.6M | $5.5M | $6.7M | $8.0M | $10.4M | $11.9M | $14.4M | $11.0M | $12.5M | $14.1M | $2.5M | $2.8M | $3.0M | $645.0K | $850.0K | $1.1M | $1.4M | $1.6M | ||||
| Cash And Cash Equivalents At Carrying Value | $648.3M | $721.5M | $793.0M | $890.9M | $961.4M | $457.0M | $572.1M | $340.4M | $293.8M | $361.5M | $372.8M | $407.4M | ||||||||||||
| Accounts Receivable Net Current | $136.0K | $233.0K | $0.00 | $45.1M | $50.0M | $0.00 | $10.0M | $2.0M | $2.8M | $489.0K | $1.0M | $46.0K | $160.0K | |||||||||||
| Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities | $1.4M | $375.0K | $199.0K | $224.0K | ||||||||||||||||||||
| Long Term Debt Noncurrent | $8.5M | $30.8M | $30.6M | $30.5M | $30.4M | $30.2M | $30.1M | $30.0M | $29.8M | $29.6M | $29.5M | $14.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $39.5M | $38.1M | $32.5M | $26.8M | $12.1M | $6.5M | $3.1M | $1.0M | $515.0K |
| Payments To Acquire Property Plant And Equipment | $2.4M | $1.2M | $2.9M | $19.0M | $2.0M | $1.2M | $1.6M | $1.2M | $1.1M |
| Net Cash Provided By Used In Operating Activities | -$249.7M | -$164.7M | -$60.6M | -$86.1M | -$14.8M | -$17.8M | -$28.6M | -$26.1M | -$1.4M |
| Net Cash Provided By Used In Investing Activities | -$2.4M | -$1.2M | -$2.9M | -$19.0M | -$2.0M | -$1.2M | -$1.6M | -$1.2M | -$1.1M |
| Increase Decrease In Research And Development Incentives Receivable | -$2.9M | $11.9M | $3.7M | $9.7M | $1.9M | $1.8M | $383.0K | $3.6M | $1.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.8M | $2.0M | $2.1M | $2.0M | $3.0M | -$502.0K | $2.7M | $1.3M | $330.0K |
| Increase Decrease In Deferred Revenue | -$69.2M | -$32.0M | $69.0M | -$2.1M | $37.1M | $24.6M | -$9.3M | -$3.9M | $14.1M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $4.1M | $9.7M | $2.4M | $12.4M | $1.2M | $4.8M | -$852.0K | $2.6M | $1.3M |
| Increase Decrease In Accounts Payable | -$6.9M | $3.1M | $8.0M | $2.6M | $1.2M | -$663.0K | $220.0K | -$169.0K | $67.0K |
| Depreciation Depletion And Amortization | $6.4M | $7.2M | $6.5M | $3.7M | $1.4M | $1.3M | $960.0K | $712.0K | $332.0K |
| Net Cash Provided By Used In Financing Activities | -$131.0K | $519.8M | $250.0M | $6.7M | $320.7M | $62.8M | $58.4M | $25.4M | $57.9M |
| Increase Decrease In Other Noncurrent Liabilities | $189.0K | $509.0K | $668.0K | $710.0K | $517.0K | $1.1M | $543.0K | $383.0K | |
| Increase Decrease In Operating Lease Right Of Use Assets | -$4.6M | -$4.4M | -$4.2M | -$2.7M | -$404.0K | -$771.0K | -$712.0K | ||
| Proceeds From Stock Options Exercised | $37.0K | $7.5M | $682.0K | $989.0K | $7.2M | $271.0K | $143.0K | $1.0K | $1.0K |
| Increase Decrease In Accounts Receivable | -$2.5M | $1.6M | -$4.5M | $2.1M | -$4.9M | $400.0K | |||
| Payments Of Stock Issuance Costs | $11.4M | $16.0M | $200.0K | $16.1M | $1.9M | $8.5M | $327.0K | $587.0K | |
| Increase Decrease In Operating Lease Liability | -$5.5M | -$4.9M | -$4.1M | -$2.1M | -$582.0K | -$621.0K | -$709.0K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $804.0K | -$694.0K | $1.3M | -$1.1M | -$1.2M | $19.0K | |||
| Increase Decrease In Other Operating Assets | $1.6M | $122.0K | $397.0K | $301.0K | $1.0M | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$1.2M | $19.0K | $465.0K | -$2.4M | $2.9M | ||||
| Proceeds From Issuance Of Common Stock | $544.1M | $249.3M | $5.7M | $291.0M | $48.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q1 2020 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $9.6M | $9.3M | $9.0M | $10.2M | $3.8M | $2.1M | $276.0K | |||||||
| Payments To Acquire Property Plant And Equipment | $604.0K | $12.0K | $2.1M | $4.8M | $623.0K | $320.0K | $418.0K | |||||||
| Net Cash Provided By Used In Operating Activities | -$86.4M | -$70.9M | -$46.4M | -$26.4M | -$13.7M | $21.2M | -$5.2M | |||||||
| Net Cash Provided By Used In Investing Activities | -$604.0K | -$12.0K | -$2.1M | -$4.8M | -$623.0K | -$320.0K | -$418.0K | |||||||
| Increase Decrease In Research And Development Incentives Receivable | $9.3M | $15.3M | $6.8M | $2.8M | $2.3M | $2.1M | $1.7M | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.0M | $8.4M | $1.7M | $1.3M | $922.0K | -$347.0K | $215.0K | |||||||
| Increase Decrease In Deferred Revenue | -$9.7M | -$19.6M | -$4.9M | -$3.9M | $236.0K | $30.1M | -$5.3M | |||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$8.2M | -$5.4M | -$3.1M | -$2.3M | -$1.9M | -$464.0K | -$783.0K | |||||||
| Increase Decrease In Accounts Payable | -$5.0M | -$5.9M | -$2.0M | -$255.0K | -$304.0K | $2.7M | $415.0K | |||||||
| Depreciation Depletion And Amortization | $1.6M | $1.7M | $1.6M | $422.0K | $325.0K | $305.0K | $213.0K | |||||||
| Net Cash Provided By Used In Financing Activities | -$41.0K | $1.9M | $2.7M | $450.0K | $74.1M | $2.0K | $34.0K | |||||||
| Increase Decrease In Other Noncurrent Liabilities | $59.0K | $160.0K | $178.0K | $171.0K | $152.0K | $191.0K | ||||||||
| Increase Decrease In Operating Lease Right Of Use Assets | -$1.1M | -$1.1M | -$1.0M | -$650.0K | $2.4M | -$187.0K | -$176.0K | |||||||
| Proceeds From Stock Options Exercised | $2.0K | $1.9M | $2.0K | $450.0K | $284.0K | $2.0K | ||||||||
| Increase Decrease In Accounts Receivable | $133.0K | -$2.5M | -$991.0K | -$3.5M | $846.0K | -$4.9M | ||||||||
| Payments Of Stock Issuance Costs | $11.4M | $15.5M | $400.0K | $100.0K | $900.0K | $400.0K | $1.8M | $1.8M | $8.4M | |||||
| Increase Decrease In Operating Lease Liability | -$1.3M | -$1.2M | -$1.0M | -$105.0K | $2.5M | |||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $468.0K | -$416.0K | $453.0K | -$603.0K | ||||||||||
| Increase Decrease In Other Operating Assets | $748.0K | $353.0K | $215.0K | -$125.0K | ||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$603.0K | $182.0K | -$3.3M | $1.6M | ||||||||||
| Proceeds From Issuance Of Common Stock | $2.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.16 | -$2.90 | -$5.08 | -$3.80 | -$2.67 | -$2.66 | -$2.77 | -$49.78 | -$48.81 |
| Earnings Per Share Basic | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 | $-2.66 | $-2.77 | ||
| Common Stock Shares Outstanding | 69.4M | 69.1M | 42.4M | 29.9M | 29.6M | 21.1M | 18.0M | 814.7K | |
| Common Stock Shares Issued | 69.4M | 69.1M | 42.4M | 29.9M | 29.6M | 21.1M | 18.0M | 898.7K | |
| Common Stock Shares Authorized | 159.7M | 155.9M | 59.6M | 57.8M | 55.3M | 32.0M | 32.0M | 15.5M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 19.1M | 11.0M | 438.9K | 333.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.85 | -$1.14 | -$0.88 | -$0.74 | -$0.77 | -$0.62 | -$1.26 | -$1.41 | -$1.30 | -$0.96 | -$0.90 | -$0.93 | -$0.59 | -$0.74 | -$0.73 | -$0.83 | -$0.52 | -$0.67 | -$0.63 | -$0.25 | -$0.53 | -$1.40 | -$7.80 | -$13.19 | -$17.73 | -$11.85 | -$6.38 |
| Earnings Per Share Basic | $-0.85 | $-1.14 | $-0.88 | $-0.74 | $-0.77 | $-0.62 | $-1.26 | $-1.41 | $-1.30 | $-0.96 | $-0.90 | $-0.93 | $-0.59 | $-0.74 | $-0.73 | $-0.52 | $-0.67 | ||||||||||
| Common Stock Shares Outstanding | 69.3M | 69.3M | 69.2M | 69.0M | 68.9M | 42.6M | 42.4M | 30.6M | 30.0M | 29.7M | 29.7M | 29.6M | 25.6M | 24.1M | 23.5M | 20.9M | 18.1M | 18.0M | 17.9M | 17.9M | |||||||
| Common Stock Shares Issued | 69.3M | 69.3M | 69.2M | 69.0M | 68.9M | 42.6M | 42.4M | 30.6M | 30.0M | 29.7M | 29.7M | 29.6M | 25.6M | 24.1M | 23.5M | 20.9M | 18.1M | 18.0M | 17.9M | 17.9M | |||||||
| Common Stock Shares Authorized | 159.7M | 159.8M | 158.5M | 155.9M | 154.4M | 61.9M | 59.6M | 59.6M | 59.6M | 57.8M | 57.8M | 57.1M | 55.3M | 55.3M | 32.0M | 32.0M | 32.0M | 32.0M | 32.0M | 32.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 22.1M | 21.1M | 19.4M | 18.1M | 18.0M | 17.9M | 17.9M | 7.3M | 834.0K | 503.3K | 433.8K | 420.1K | 397.5K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $39.5M | $38.1M | $32.5M | $26.8M | $12.1M | $6.5M | $2.7M | $800.0K | $401.0K |
| Interest And Other Income | $28.5M | $34.3M | $14.0M | $5.8M | $120.0K | $683.0K | $814.0K | $169.0K | $50.0K |
| Additional Paid In Capital | $1.51B | $1.47B | $883.4M | $601.1M | $567.6M | $249.9M | $195.1M | $1.9M | |
| Stock Issued During Period Value New Issues | $544.1M | $249.3M | $5.7M | $291.0M | $48.1M | $56.4M | |||
| Interest Paid Net | $1.4M | $2.8M | $2.8M | $2.5M | $378.0K | ||||
| Increase Decrease Capital Expenditures Incurred But Not Yet Paid | -$4.0K | -$1.7M | $1.6M | $324.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.8M | $9.4M | $9.6M | $9.2M | $9.3M | $9.3M | $7.4M | $8.2M | $9.0M | $5.4M | $5.7M | $10.2M | $2.7M | $2.6M | $3.8M | $1.5M | $1.3M | $2.1M | $819.0K | $612.0K | $172.0K | $203.0K | $309.0K | $198.0K |
| Interest And Other Income | $6.7M | $7.5M | $8.4M | $10.6M | $7.8M | $5.6M | $4.0M | $812.0K | $2.9M | $2.0M | $908.0K | $218.0K | $24.0K | $23.0K | $15.0K | $72.0K | $371.0K | $212.0K | $440.0K | $90.0K | $64.0K | $26.0K | $52.0K | |
| Additional Paid In Capital | $1.50B | $1.49B | $1.48B | $1.46B | $1.45B | $894.6M | $875.2M | $633.3M | $612.9M | $589.7M | $584.2M | $578.3M | $374.0M | $330.9M | $312.8M | $246.4M | $198.5M | $197.2M | $193.9M | $193.2M | ||||
| Stock Issued During Period Value New Issues | $544.1M | $234.5M | $12.1M | $2.7M | $29.8M | $14.0M | $58.8M | $46.3M | $56.5M | |||||||||||||||
| Interest Paid Net | $686.0K | $679.0K | $664.0K | $429.0K | ||||||||||||||||||||
| Increase Decrease Capital Expenditures Incurred But Not Yet Paid | $26.0K | -$1.7M | $1.6M |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.